Capitolis Liquid Global Markets’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.24M Sell
2,900
-87,100
-97% -$35.7M 0.01% 325
2026
Q2
$35.1M Buy
+90,000
New +$38M 0.15% 104
2026
Q1
– Sell
-21,340
Closed -$10M – 369
2025
Q4
$10M Buy
+21,340
New +$9.9M 0.06% 152

Other funds holding HCA

Capitolis Liquid Global Markets's HCA Position: Q3 2026 in Review

Capitolis Liquid Global Markets reduced its HCA Healthcare (HCA) stake by 97% in Q3 2026, selling an estimated $35.7M and leaving 2,900 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #325.

Capitolis Liquid Global Markets first reported a position in HCA in Q4 2025 and has held it in 3 quarters since. The position peaked at $35.1M in Q2 2026. 1,359 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Capitolis Liquid Global Markets held 2,900 shares of HCA Healthcare worth $1.24M as of Q3 2026.
  • Capitolis Liquid Global Markets sold 87,100 HCA Healthcare shares in Q3 2026, an estimated $35.7M.
  • HCA Healthcare made up 0.01% of Capitolis Liquid Global Markets's portfolio in Q3 2026, its #325 holding.
  • Capitolis Liquid Global Markets first reported a position in HCA Healthcare in Q4 2025 and has held it in 3 quarters since.
  • Capitolis Liquid Global Markets's HCA Healthcare position peaked at $35.1M in Q2 2026.
  • 1,359 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q3 2026, filed 12 Nov 2026.